From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine - Wikidata - awgldk - TriplyDB

From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine

From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine

http://www.wikidata.org/entity/Q33466255

about

Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines Dysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic Agents Strategy for Designing a Synthetic Tumor Vaccine: Multi-Component, Multivalency and Antigen Modification Glycotherapy: new advances inspire a reemergence of glycans in medicine Cancer vaccines and carbohydrate epitopes.Human Cancer Antigen Globo H Is a Cell-Surface Ligand for Human Ribonuclease 1.Solving the convergence problem in the synthesis of triantennary N-glycan relevant to prostate-specific membrane antigen (PSMA).Immunologic mapping of glycomes: implications for cancer diagnosis and therapy A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission Natural and Induced Humoral Responses to MUC1.A vision for vaccines built from fully synthetic tumor-associated antigens: from the laboratory to the clinic Synthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience.Synthesis of the tumor associative α-aminooxy disaccharide of the TF antigen and its conjugation to a polysaccharide immune stimulant.The promise of glycomics, glycan arrays and carbohydrate-based vaccines.Carbohydrate-based vaccines: challenges and opportunities.Carbohydrate chemistry in drug discovery.Toward automated oligosaccharide synthesis.Recent advances in developing synthetic carbohydrate-based vaccines for cancer immunotherapies.The sweet side of tumor immunotherapy.Multivalent glyco(cyclo)peptides.Recent progress in the field of neoglycoconjugate chemistry.Recent Developments in Synthetic Carbohydrate-Based Diagnostics, Vaccines, and Therapeutics.Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression.Synthetically defined glycoprotein vaccines: current status and future directions.Immunological evaluation of the entirely carbohydrate-based Thomsen-Friedenreich - PS B conjugate.Synthesis and Evaluation of GM2-Monophosphoryl Lipid A Conjugate as a Fully Synthetic Self-Adjuvant Cancer Vaccine.Affinity of monoclonal antibodies for Globo-series glycans Recent progress in antitumoral synthetic vaccines.One-pot multi-enzyme (OPME) chemoenzymatic synthesis of sialyl-Tn-MUC1 and sialyl-T-MUC1 glycopeptides containing natural or non-natural sialic acid.Heterovalent Glycodendrimers as Epitope Carriers for Antitumor Synthetic Vaccines.Immune activation with peptide assemblies carrying Lewis y tumor-associated carbohydrate antigen.Chemoenzymatic synthesis of neoglycoproteins driven by the assessment of protein surface reactivity

P2860

Q26740513-EC47F716-7D48-42A3-9575-5A6BE49F8A58 Q26771367-8EE6DAD1-885C-48A9-AD4E-801847943803 Q27001592-7CE6715D-62AA-4F11-A8DB-2F5C893F503C Q27027997-10E760D4-1ECF-4094-9DED-0AD986B9AE29 Q35525289-57A4157E-BAE4-4001-9623-6BB62FA8CBB4 Q36063340-EE384430-4B95-4A7F-A0DC-27496B6E9175 Q36313627-24BBB90D-3E49-42EB-88FD-FC9E10B01C5C Q36543504-05C6F7AD-3BA4-49B6-B29F-E659BFE121D5 Q36841027-769374F6-1759-4348-963E-6BE909264D06 Q37137385-51191020-1A01-4550-B352-858DE7163D50 Q37303845-48688914-CCE3-44F8-86BE-443B9F67D921 Q37608314-4D8D9D78-BE0A-4DFB-9430-282E82FBA94D Q37642032-BE7535BE-D6DB-4FBC-A4B1-98B1DC5F3D94 Q37689188-0031A38F-1189-4BFD-BB17-78CD6377284B Q37810597-719B99F6-B872-43ED-BAE8-65DB41A719EE Q37853437-42427DD0-C7B1-4946-B72F-B42F3DC248E3 Q37962848-05FE6B5B-4CC6-4CBA-B12B-F84FA4F76AD9 Q37993590-1C860B06-C4BA-4B77-BC48-62E46F70A73C Q38031282-96831E54-8560-4767-94F4-11FA4A848775 Q38069441-D27962BE-CE70-4061-8D53-29F9249EC11D Q38472393-B5372318-2E23-4BF5-A8CE-9CF2EB92C020 Q38533442-C5595366-76B5-48AD-B506-0122709C00C5 Q39079672-DFD0C2EC-55A1-4367-81AF-1A9F5C7B438F Q39375701-3B69A2C5-718D-4863-80E4-D8EC9506A263 Q39935587-430485C0-AE77-4AFF-8A40-72B4A540B316 Q41194257-75CEA75A-F075-4DD1-9C3D-B8B103655907 Q42149743-2B64A276-1483-439D-9332-FD204EF14175 Q43007810-0FFA1023-5415-417D-8462-A478BEB129B3 Q43076252-DDDCF93A-777B-4560-B453-8A7D05094796 Q48169265-6B98CA69-F761-487C-928B-05ACDA05B0FA Q51141205-4F2E8877-89C1-494B-8000-F1EB9AB4C37D Q56036811-5FA634AF-304B-4A60-AB1D-C7ABECE3C7CF

P2860

From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine

http://www.wikidata.org/entity/Q33466255

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine

@ast

From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine

@en

type

label

From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine

@ast

From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine

@en

prefLabel

From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine

@ast

From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine

@en

P1433

Q33466255-12F40EFD-F78A-4A2A-BD39-30E9C41AB2D3

P1476

Q33466255-5831DDB7-4993-4CC6-89E4-4A35226F798D

P2093

Q33466255-272D3C0D-63CA-48E3-9422-E86D645DD99F

Q33466255-5EB1A773-99BB-4850-986E-ED65CA5077C1

Q33466255-62C8CE7F-7576-4D6E-8104-E8F6E497289E

Q33466255-6B9A9DE0-1C95-4B71-B7AC-E8C0436FEAAC

Q33466255-9C1AC365-755D-407F-967E-7249D3B1A241

Q33466255-CC2B6ADE-202B-486C-9B8E-AECE8495C649

Q33466255-E06448B7-AC26-441F-AFE5-1554E1E4ADA4

Q33466255-F564BE15-3508-4CF5-8EF8-AC911EEFADE6

P2860

Q33466255-01B47CDE-83AC-429F-8265-3154517314B6

Q33466255-05588F3F-C8A4-4AE6-812B-1120D5D035C3

Q33466255-20EC39D5-0929-4269-86C8-FB6D0BC6FB62

Q33466255-58851E12-41FB-4CC0-A2D1-3E198E7931D2

Q33466255-5F511904-3A18-46C4-8289-2C8572DA9424

Q33466255-7AC845F2-FD67-4030-90E0-F1E0A5BA039F

Q33466255-851AF136-4DAC-4582-820F-FD4B2AE51595

Q33466255-977238B6-3FAD-4489-B1BD-210B95CC4B2A

Q33466255-B78336CE-306E-4B7E-97A9-804D9F496DC3

Q33466255-E4E06DC5-241E-4FE4-A5C8-3A25A9E5C2B7

P304

Q33466255-0FEFA4C4-5288-4383-80A5-409CC5C30C9D

P31

Q33466255-C1D8500D-74EE-4AB8-B492-D5B586CBBF93

P356

Q33466255-AA1A5AEA-B56C-4C37-85C4-0DD255ED35EA

P407

Q33466255-A6DCA98B-9570-470F-AB3E-76B4D5BA14EC

P433

Q33466255-8EC193D3-2913-4C22-A468-138B157979E0

P478

Q33466255-55E1E0DD-C099-4CBC-8BBB-83884096ADF0

P50

Q33466255-0AE9F7AD-3ABE-4625-96ED-C448667E160B

Q33466255-D60540BB-7005-4BE1-BBDB-56E9860D3F48

P577

Q33466255-44E21B9F-24E7-44A7-9201-7E77F18302E4

P5875

Q33466255-EDA58BF9-5BA7-4845-80C1-E3081AB8ED5F

P698

Q33466255-63CBDFD2-9B33-48ED-B039-8A0480873A0B

P932

Q33466255-2A5A0523-2542-4BF8-87CA-7921FADFFBE1

P356

P1433

Journal of the American Chemical Society

P1476

From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine

@en

P2093

Dongjoo Lee

http://www.w3.org/2001/XMLSchema#string

Govind Ragupathi

http://www.w3.org/2001/XMLSchema#string

Guangbin Yang

http://www.w3.org/2001/XMLSchema#string

Jianglong Zhu

http://www.w3.org/2001/XMLSchema#string

Maria K Spassova

http://www.w3.org/2001/XMLSchema#string

Payal Damani

http://www.w3.org/2001/XMLSchema#string

Philip O Livingston

http://www.w3.org/2001/XMLSchema#string

Samuel J Danishefsky

http://www.w3.org/2001/XMLSchema#string

P2860

Separation of positional isomers of oligosaccharides and glycopeptides by high-performance anion-exchange chromatography with pulsed amperometric detection.

Robust immune responses elicited by a fully synthetic three-component vaccine.

From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines Frequently used abbreviations are listed in the appendix.

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.

Prospects for total synthesis: a vision for a totally synthetic vaccine targeting epithelial tumors.

Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: a synthetic route to anticancer vaccine candidates.

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.

Immunization of ovarian cancer patients with a synthetic Lewis(y)-protein conjugate vaccine: a phase 1 trial.

Biomimetic synthesis of the tumor-associated (2,3)-sialyl-T antigen and its incorporation into glycopeptide antigens from the mucins MUC1 and MUC4.

Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and a T-cell epitope for the induction of a highly specific humoral immune response.

P304

9298-9303

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/JA901415S

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P50

Ouathek Ouerfelli

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26284238

http://www.w3.org/2001/XMLSchema#string

P698

19518111

http://www.w3.org/2001/XMLSchema#string

P932

2716484

http://www.w3.org/2001/XMLSchema#string